Basic nutrients
Omega-3 fatty acids
Amino acids
Minerals
Vitamins
Vitamin capsules
Liquid vitamins
Vitamin complex
Plant substances & superfoods
Antioxidants
Plant substances
Superfoods
Vital mushrooms
Functional nutrients
Enzymes & fiber
Melatonine
Probiotics
Bones, joints & muscles
Joints
Bones
Muscles
Weight loss & metabolism
Lose weight
Metabolism
Drainage
Mental health & performance
Memory & concentration
Stress, exhaustion & burnout
Mood
Sleep & fatigue
Energy
Sleep disorder
Iron deficiency
Heart health
Circulation
Heart protection
Blood pressure
Cholesterol
Women's health
Pregnancy & breastfeeding
Fertility
Hormone balance
PMS
Libido
Menopause
Recurrent cystitis
Men's health
Libido & erectile dysfunction
Prostate
Stomach & intestine
Intestinal cleansing & build-up
Digestive problems
Bloating
Heartburn
Hemorrhoids
Parasites
Beauty
Skin
Hair
Connective tissue
Liver health
Detoxification
Liver protection
Immune system
Strenghten the immune system
Allergy
Blood sugar
Eyes & eyesight
Inflammations
Histamine Intolerance
Pain
Longevity & cellular regeneration
Acid-base balance
Value packs
Card Value:
Qty
Discount:
You save:
Referral discount:
Grand Total:
Neu
Raised readings do not appear out of nowhere. Over years, the body can compensate for stiffer vessel walls, thicker blood and a nervous system that runs a little “hotter” than it should. The visible signs—headache after effort, a heavier pulse under stress, a quicker flush when climbing stairs—are often the end of a longer chain. The more useful question is what sits underneath the number: how fluid the blood is, how responsive the vascular lining remains and how relaxed or tense the smooth muscle of the vessel wall feels during an ordinary day.
That is the logic behind a combination built deliberately across three levels. One product alone tends to focus on one part of the picture. A routine designed around several distinct roles can address the structure more completely: the blood itself, the vessel wall and the tone of the musculature that narrows or opens the vessel.
Clot formation is essential when an injury occurs, and fibrin (a protein in the blood that makes it clot)—the string‑like protein that forms a mesh—is central to that process. Trouble begins when fibrin deposition and related micro‑aggregates accumulate where no wound exists, adding resistance to flow. The heart must then work against a subtly higher internal friction across thousands of vessel branches.
Nattokinase is a proteolytic enzyme isolated from natto, a traditional fermented soybean food. In biochemical terms, it can break down fibrin directly and may influence the body’s own fibrinolytic (dissolving fibrin, so clot-dissolving) system, including plasmin, the enzyme tasked with dissolving fibrin. By acting at the level of fibrin, the discussion shifts from a symptom (“the pressure is high”) to a mechanism (“the fluid moves with less internal resistance”). The editorial point is not to present nattokinase as a medicine. It is to show why an enzyme with fibrin‑targeting activity belongs in a conversation about blood fluidity and overall cardiovascular ease.
There is also emerging work around angiotensin‑converting enzyme (ACE) interactions in vitro and in small human studies. That context should be read as preliminary and mechanistic; any supplement positioning must remain within food‑supplement law and avoid treatment promises. The practical takeaway is simpler: an enzyme relevant to fibrin turnover belongs to the “flow” side of the routine, which is not the same level as vessel elasticity or smooth‑muscle tone.
The inner lining of every artery and arteriole—the endothelium (the wafer-thin inner lining of the blood vessels)—releases signals that tell the vessel to relax or constrict. Nitric oxide (a gas the body makes that widens the blood vessels) (NO) is one of the most important of these signals. When the endothelial environment is unsettled by chronic low‑grade inflammation (the body’s defence reaction, harmful when it becomes chronic), oxidative stress (cell damage from unstable oxygen molecules (free radicals)) or an unfavourable lipid milieu, NO bioavailability (how much of a nutrient the body can actually absorb and use) can fall. Vessels then spend more time on the constricted side, and a once‑flexible system can begin to feel “tighter”.
Marine omega‑3 fatty acids, EPA and DHA, integrate into cell membranes (the outer layer that surrounds every cell) and influence eicosanoid balance, inflammation‑resolution mediators (resolvins, protectins) and endothelial signalling. This is not a stimulant effect; it is membrane biology and vascular physiology. Several meta‑analyses report modest average reductions in systolic (the upper blood pressure reading) and diastolic (the lower blood pressure reading) blood pressure with EPA/DHA intakes in studied populations, particularly where baseline values are elevated or high‑normal. The broader value sits in endothelial support and long‑term vessel comfort rather than a dramatic short‑term drop.
Omega‑3 status also interacts with autonomic balance and heart‑rate variability (HRV), a marker of how flexibly the cardiovascular system responds to daily stressors. A system that can move in and out of demand smoothly tends to feel calmer under ordinary pressure.
Vessels are wrapped in smooth muscle. Calcium influx tightens that muscle; less calcium entry and better electrolyte balance ease it. Magnesium sits directly in this conversation. At cellular level it modulates calcium channels and acts as a cofactor in numerous enzymes (proteins that set the body's chemical processes in motion), several of which influence vascular tone (the resting tension of the blood vessel walls) and nitric‑oxide pathways. That is one reason a whole class of prescription medicines targets calcium channels; magnesium is not a drug, but it belongs to the same physiological crossroads from a nutritional angle.
Magnesium also matters to the nervous system’s baseline. Sympathetic drive—adrenaline‑led “push”—makes vessels narrower and the heartbeat quicker. Nutritional support for a steadier autonomic background can translate into a day that feels less pressurised, both literally and figuratively. Finally, cardiac electrophysiology depends on stable electrolytes; low magnesium status is a recognised contributor to palpitations in some individuals, although that observation should not be turned into a diagnosis in consumer copy.
Many “everything‑in‑one” formulas look attractive at first glance. The practical constraint is capsule space. When several actives share the same small format, each one may occupy only a token amount. That can make the label look strong while leaving the question of meaningful dose unanswered. This bundle uses separate products deliberately: one for fibrin and flow (nattokinase), one for endothelial and membrane biology (omega‑3), and one for smooth‑muscle tone and autonomic balance (magnesium). Each can be assessed on its own amount, source and role.
Equally important is the architecture. Blood pressure is rarely a single‑level issue. Flow, vessel lining and muscular tone are different places in the same story. A routine that acknowledges those levels can make more sense than expecting one compressed capsule to do all three jobs.
Nutritional routines work by foundation, not by shock. Changes, where they occur, tend to show up as a calmer pulse under ordinary stress, less sense of “push” during effort and a steadier recovery after exertion. Some people notice these shifts within two to four weeks; measured differences often require six to twelve weeks of consistent use and lifestyle attention. Supplements remain one part of a larger approach including movement, body weight, sleep and dietary pattern.
- Adults seeking structured, non‑pharmaceutical support around cardiovascular comfort and vessel function within normal life.
- Individuals with high‑normal readings who are building lifestyle foundations early, and adults in midlife as natural vessel stiffness increases.
- People whose diet is light on oily fish and leafy greens, where omega‑3 and magnesium intake may be lower than ideal.
- Those in sustained high‑stress periods where sympathetic drive is more prominent and magnesium demand can rise.
This routine is not a replacement for medical care. Anyone on prescription medicines, with diagnosed hypertension (high blood pressure), a history of cardiovascular disease or bleeding disorders should involve a clinician in decisions about supplements.
Most people tolerate these nutrients well, but awareness helps make a routine safer and more comfortable. Potential side effects and cautions include:
Used thoughtfully and with appropriate medical oversight where indicated, the routine is designed to be calm and sustainable rather than aggressive.
Each component is produced under European quality standards with batch‑tested raw materials. Omega‑3 comes from marine sources with standardised EPA/DHA content; nattokinase is produced from fermented soy using controlled processes to achieve defined enzyme activity (fibrinolytic units, FU); magnesium is provided in a bioavailable (meaning the body can actually absorb and use it) form. No artificial colours or preservatives are added, and non‑GMO sourcing is observed.
Mechanism recap: Nattokinase is a serine protease with fibrinolytic activity. It can directly cleave fibrin and has been reported to increase endogenous fibrinolysis via effects on plasminogen activators in some models. A mechanistic secondary note concerns in vitro ACE interaction, which should be treated as preliminary in consumer contexts.
Study landscape in brief: Small human trials and observational work offer mechanistic signals. Kim et al. (2008) reported changes in blood pressure over 8 weeks in a randomised, placebo (a dummy treatment used for comparison)‑controlled trial of nattokinase; Hsia et al. (2009) observed reductions in fibrinogen, factor VII and factor VIII after supplementation (topping up a substance the body is short of). Earlier discovery work by Sumi and colleagues in the 1980s characterised fibrinolytic properties from natto extracts, which framed subsequent research. Interpretation: sample sizes are modest and outcomes heterogeneous; read these as supportive of the “flow/fibrin” role, not as treatment evidence.
Dose reasoning: Commercial nattokinase products are standardised by activity (FU) rather than mass, often in the region commonly seen in the supplement market. Meaningful dosing depends on declared FU per serving and demonstrated stability over shelf life. An NRV does not exist for enzymes; dose judgment is therefore based on activity units used in published human work and manufacturer specifications. Follow the labelled directions and do not escalate beyond them without clinical advice—especially in the presence of bleeding risk.
Form and quality: Nattokinase should be standardised to a defined fibrinolytic activity (FU) and produced through controlled fermentation with purification that removes vitamin K2 variability from raw natto where relevant. Allergen communication (soy source) should be clear. Stability testing matters because enzyme activity can decline with moisture and heat; desiccants and proper storage reduce this risk.
Mechanism recap: EPA and DHA incorporate into phospholipid bilayers, shifting eicosanoid balance and supporting pro‑resolving mediators (resolvins/protectins). They modulate endothelial NO signalling, reduce triglycerides (blood fats) and can influence autonomic markers such as HRV.
Study landscape in brief: Multiple meta‑analyses (e.g., Miller et al., 2014; Abdelhamid et al., 2020 Cochrane) show modest average BP reductions in studied cohorts, especially with elevated baselines. Trials also link marine omega‑3 to cardiovascular endpoints and plaque stability (e.g., Thies et al., 2003) in specific contexts. Prescription‑strength icosapent ethyl trials (e.g., high‑dose EPA) concern a medicine and cannot be translated into supplement claims; they are mentioned only to illustrate dose‑specific research landscapes.
Dose reasoning: UK/EU authorised wording around normal blood pressure requires 3 g/day EPA+DHA combined, with mandatory warnings and conditions. Many daily intakes in food supplements focus on heart function at 250 mg/day EPA+DHA or higher according to label. The right amount for a given product is the amount it actually provides—claims and consumer wording must match that label. Tolerability considerations (GI upset) improve with split dosing and taking with meals.
Form and quality: Omega‑3 concentrates come as ethyl esters or re‑esterified triglycerides; re‑esterified triglyceride forms typically show good bioavailability in comparative studies, though both forms can be effective. Oxidation status (e.g., TOTOX) and freshness are meaningful quality markers; enteric‑coated capsules or taking with food can limit “fishy burps”. Sustainability and contaminant controls (heavy metals, dioxins, PCBs) should be evidenced by supplier certificates and batch testing.
Mechanism recap: Magnesium influences calcium channel behaviour, smooth‑muscle relaxation and NO pathways, and it stabilises cardiac electrophysiology. It also contributes to normal functioning of the nervous system and normal psychological function—editorially relevant because sympathetic tone interacts with vessel constriction.
Study landscape in brief: Meta‑analyses (Kass et al., 2012; Zhang et al., 2016) indicate small but statistically significant average BP changes, with larger effects in individuals with lower baseline magnesium status. Heterogeneity reflects different salts, doses and durations.
Dose reasoning: Typical supplemental intakes for general adult use often fall in the mid‑hundreds of milligrams of elemental magnesium per day, split to improve GI tolerance. The appropriate amount is the one on the label; higher single doses more often cause loose stools. People with impaired kidney function require medical oversight due to altered magnesium handling.
Form and quality: Salts differ. Magnesium citrate, glycinate and malate are commonly chosen for bioavailability and comfort; oxide provides higher elemental content per capsule but can be less well tolerated in some individuals. The product label states the elemental magnesium per serving; that figure, not the salt weight, carries the decision.
Architecture is the advantage: flow, lining and tone. Nattokinase speaks to flow by addressing fibrin and micro‑aggregation. Omega‑3 embeds in the lining to support endothelial signalling and long‑term vessel comfort. Magnesium modulates tone by easing calcium’s contractile signal in smooth muscle and by supporting a calmer autonomic baseline. Where these levels interact—NO signalling is a good example—omega‑3 can support production while magnesium helps the muscular side respond. If flow is easier at the same time, the system no longer has to push as hard against internal resistance. The combined routine therefore reads as a map of the problem rather than three unrelated names on a label.
Routines work best when they are steady and simple:
Because these are food supplements, the routine sits alongside—not instead of—movement, sleep, stress management and diet. A calm, repeated pattern beats occasional, irregular use.
Prudence keeps routines safe. Discuss with a clinician if any of the following apply:
Progress is clearer with a simple framework:
An NRV is a nutritional reference, not a performance target. Enzymes like nattokinase have no NRV; meaningful amounts are judged by activity units and human research context. For omega‑3, authorised claims have specific intake thresholds with legal wording and warnings; lower or different intakes relate to other authorised effects (e.g., normal heart function at 250 mg/day). For magnesium, the elemental amount, the salt form and individual tolerance define what is suitable. Always match consumer‑facing statements to the exact label.
Nattokinase: Commonly taken once daily, ideally on an empty stomach or at bedtime, away from protein‑rich meals.
Omega‑3: Take with a main meal that contains some fat to support absorption of EPA and DHA.
Magnesium: Take in the evening or split across the day. Evening use is popular for its contribution to normal muscle function and a calmer end‑of‑day routine.
The three products can be used on the same day within one routine. Consistency over weeks matters more than the exact clock time. Do not exceed the recommended daily amount.
Food supplements should not be used as a substitute for a varied and balanced diet and a healthy lifestyle. Store in a cool, dry place out of the reach of children.
Do not exceed the recommended daily dose.
Store in a cool, dry place away from light. Keep out of reach of young children.
Composition:
The pack contains 3 separate preparations. Composition and amounts for each preparation:
Composition of Nattokinase capsules:
cellulose powder, nattokinase, hydroxypropylmethylcellulose (vegan capsule shell), ascorbyl palmitate
Composition Omega 3 capsules high dose:
Fish oil, gelatine capsule (bovine gelatine, glycerine E422, water)
Thanks to the patented EPAX purification step, organic contaminants (e.g. dioxins, PCBs, heavy metals, iodine and pesticides) in the fish oil are reduced to the lowest possible level.
Quantities per capsule:
Composition Magnesium complex:
Magnesium carbonate, magnesium citrate, magnesium oxide, magnesium glycerophosphate, hydroxypropyl methylcellulose (capsule shell)
Magnesium
Capsule space is finite. Separate products allow each ingredient to be present at a meaningful amount and to keep its own role: nattokinase for the “flow” level, omega‑3 for endothelial and membrane biology, magnesium for smooth‑muscle tone and nervous‑system balance. A long single label does not automatically equal meaningful doses for each active.
Many people build a supplement routine alongside medical care, but this decision belongs with a clinician. Nattokinase has interaction potential with anticoagulants (blood-thinning medicines) and antiplatelet medicines, so medical oversight is essential. Monitoring of blood pressure should be more frequent when any change is made.
Nutritional approaches work by foundation. Some people notice a calmer pulse and steadier recovery within 2–4 weeks. Measured differences often require 6–12 weeks of consistent use alongside lifestyle measures. Supplements do not replace medical treatment.
Yes, taking EPA/DHA with a main meal that contains fat improves absorption and reduces the chance of fishy aftertaste or reflux.
Typical tolerability is good. Possible effects include loose stools with higher magnesium intakes, fishy burps or mild GI upset with omega‑3, and increased bleeding tendency with nattokinase in sensitive individuals or when combined with blood thinners. Stop use and seek advice if unusual symptoms occur.
Marine omega‑3 is derived from fish oil and is not vegetarian. Individuals with fish or shellfish allergy should avoid fish‑derived omega‑3. Nattokinase originates from fermented soy; those with soy sensitivity should seek advice. Magnesium salts are typically suitable for vegetarians and vegans, but always check the specific product label for capsule materials.
Keep omega‑3 capsules cool, dry and away from direct light. Many people store them in a cool cupboard; refrigeration can help maintain freshness in warmer months. Do not expose capsules to heat (e.g., a car glove box), and keep the lid tightly closed to protect from moisture and oxygen.
Magnesium salts differ in elemental content and tolerability. Citrate, glycinate and malate are commonly chosen for good bioavailability (how much of a nutrient the body can actually absorb and use) and comfort. Oxide contains more elemental magnesium per capsule but can be less comfortable for some. Always read the label for the elemental amount per serving rather than the salt weight.
Low‑dose aspirin has antiplatelet effects. Because nattokinase may influence bleeding tendency, medical advice is required before combining. Your clinician can weigh personal bleeding risk, procedure plans and monitoring needs.
Use a validated arm‑cuff monitor. Sit quietly for 5 minutes, feet on the floor, back supported. Take two readings one minute apart in the morning and evening for several days and average them. Track at baseline, again after 6–8 weeks and whenever lifestyle or medication changes occur.
These nutrients are commonly used for extended periods when well tolerated. Long‑term routines should be reviewed periodically with a clinician, especially if medications, diagnoses or life circumstances change. Pause nattokinase before planned surgery on medical advice.
Sources (in English):
Kim JY, Gum SN, Paik JK et al. (2008). Effects of nattokinase on blood pressure: a randomized, controlled trial. Hypertension (high blood pressure) Research, 31(8), 1583-1588. https://pubmed.ncbi.nlm.nih.gov/18971533/
Miller PE, Van Elswyk M, Alexander DD (2014). Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis (a study that pools the results of many studies) of randomized controlled trials. American Journal of Hypertension, 27(7), 885-896. https://pubmed.ncbi.nlm.nih.gov/24610882/
Zhang X, Li Y, Del Gobbo LC et al. (2016). Effects of magnesium supplementation (topping up a substance the body is short of) on blood pressure: a meta-analysis of randomized double-blind placebo (a dummy treatment used for comparison)-controlled trials. Hypertension, 68(2), 324-333. https://pubmed.ncbi.nlm.nih.gov/27402922/
Chen H, Chen L, Wang L et al. (2018). Efficacy and safety of nattokinase in patients with hypertension: a randomized controlled trial. Journal of Clinical Hypertension, 20(11), 1717-1723. https://pubmed.ncbi.nlm.nih.gov/30289221/
AbuMweis S, Jew S, Tayyem R, Agraib L (2018). Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta-analysis of randomised placebo-controlled human clinical trials. Journal of Human Nutrition and Dietetics, 31(1), 67-84. https://pubmed.ncbi.nlm.nih.gov/28675488/
Thank you for your feedback. Your review will be released shortly.
Blood Pressure Ultra by Herbano® – Nattokinase + Omega‑3 + Magnesium